In CSF, on the other hand, disease progression was associated with nominally significant increases in NAD+, arginine, saturated long-chain free fatty acids, diacylglycerides, triacylglycerides, and sphingomyelins.
← all excerpts
Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research.
1
—
—